NO20016147L - Biologiske aktive materialer - Google Patents

Biologiske aktive materialer

Info

Publication number
NO20016147L
NO20016147L NO20016147A NO20016147A NO20016147L NO 20016147 L NO20016147 L NO 20016147L NO 20016147 A NO20016147 A NO 20016147A NO 20016147 A NO20016147 A NO 20016147A NO 20016147 L NO20016147 L NO 20016147L
Authority
NO
Norway
Prior art keywords
biologically active
active materials
materials
biologically
active
Prior art date
Application number
NO20016147A
Other languages
English (en)
Other versions
NO20016147D0 (no
Inventor
Ruth Duncan
Dale Hreczuk-Hirst
Lisa German
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914187.1A external-priority patent/GB9914187D0/en
Priority claimed from GBGB9930252.3A external-priority patent/GB9930252D0/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of NO20016147D0 publication Critical patent/NO20016147D0/no
Publication of NO20016147L publication Critical patent/NO20016147L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO20016147A 1999-06-18 2001-12-17 Biologiske aktive materialer NO20016147L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914187.1A GB9914187D0 (en) 1999-06-18 1999-06-18 Biologically active materials
GBGB9930252.3A GB9930252D0 (en) 1999-12-22 1999-12-22 Biologically active molecules
PCT/GB2000/002216 WO2000078355A2 (en) 1999-06-18 2000-06-19 Biologically active materials

Publications (2)

Publication Number Publication Date
NO20016147D0 NO20016147D0 (no) 2001-12-17
NO20016147L true NO20016147L (no) 2002-01-29

Family

ID=26315678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016147A NO20016147L (no) 1999-06-18 2001-12-17 Biologiske aktive materialer

Country Status (11)

Country Link
US (1) US6818630B1 (no)
EP (1) EP1198253A2 (no)
JP (1) JP2003504312A (no)
AU (1) AU783886B2 (no)
CA (1) CA2374548A1 (no)
HK (1) HK1047884A1 (no)
IL (1) IL146795A0 (no)
MX (1) MXPA01013276A (no)
NO (1) NO20016147L (no)
NZ (1) NZ515999A (no)
WO (1) WO2000078355A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
US7838619B2 (en) 2002-01-14 2010-11-23 The General Hospital Corporation Biodegradable polyketal polymers and methods for their formation and use
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US8030459B2 (en) 2002-07-19 2011-10-04 The General Hospital Corporation Oxime conjugates and methods for their formation and use
US7947261B2 (en) * 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
EP1667726B1 (en) * 2003-09-05 2011-05-04 The General Hospital Corporation Polyacetal drug conjugates as release system
PE20100746A1 (es) 2008-12-10 2010-11-04 Mersana Therapeutics Inc Formulaciones farmaceuticas de conjugados de camptotecina-polimero biocompatibles y biodegradables
KR102366322B1 (ko) 2020-07-31 2022-02-22 주식회사 다산네트웍스 전기자전거 주행시스템

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477931B1 (en) * 1990-09-28 1994-08-17 Mercian Corporation Novel adriamycin derivatives
WO1995005199A1 (en) * 1993-08-19 1995-02-23 Dextran Products Limited Pharmaceutical preparation and a process for making same
IT1281877B1 (it) 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
EP0998303B1 (en) * 1997-06-12 2006-02-15 Innovata PLC Polymer-drug conjugate for the treatment of cancer

Also Published As

Publication number Publication date
JP2003504312A (ja) 2003-02-04
WO2000078355A3 (en) 2002-02-21
NZ515999A (en) 2004-03-26
HK1047884A1 (zh) 2003-03-14
US6818630B1 (en) 2004-11-16
EP1198253A2 (en) 2002-04-24
IL146795A0 (en) 2002-07-25
MXPA01013276A (es) 2002-06-04
NO20016147D0 (no) 2001-12-17
WO2000078355A2 (en) 2000-12-28
AU783886B2 (en) 2005-12-22
AU5413000A (en) 2001-01-09
CA2374548A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
DE60023165D1 (de) Flash-gesponnenes flächiges material
DE50010727D1 (de) Flächiges Implantat
ATE388677T1 (de) Zwischenwirbelimplantat
IS5568A (is) Lyfjafræðilega virkt morfólínól
DE60044873D1 (de) Orientierte biopolymermembrane
DE50010295D1 (de) Zwischenwirbel-nucleus-prothese
DE60038253D1 (de) Verbindungsmaterial
DE60011207D1 (de) Photothermographisches Material
DE60043058D1 (de) Dentalwerkstoffe
ATE346021T1 (de) Extrudierbares zementmaterial
ATE219157T1 (de) Gleitlager
ID27150A (id) Sediaan levotiroksin bahan farmasi
FI20000973A0 (fi) LC-suodatin
NO20016147D0 (no) Biologiske aktive materialer
DE60002843D1 (de) Agrochemische zusammensetzung
DE59902159D1 (de) Aktiver mikromischer
FR2798583B1 (fr) Implant cotyloidien
DE60129123D1 (de) BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
DE60019505D1 (de) Mikrobizide Wirksubstanzen
ATA12382000A (de) Gleitlager
FR2788685B1 (fr) Implant cothyloidien
DE60034215D1 (de) Oberflaechenaktive zusammensetzung
EE9900442A (et) Bioloogiliselt aktiivne materjal
NO20004568D0 (no) Forbrenningsovn
PL352211A1 (en) Biologically active materials

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application